Here are 10 things you should know for Friday, Oct. 30:

1. -- U.S. stock futures were pointing to slight gains for Wall Street on Friday ahead of a number of U.S. economic reports.

European stocks inched higher. Asian shares finished Friday's session mixed. Japan's Nikkei 225 rose 0.8% after the Bank of Japan left its super-easy monetary policy unchanged but kept the door open for extra stimulus.

2. -- The economic calendar in the U.S. on Friday includes personal income and personal spending for September at 8:30 a.m. EDT, the Employment Cost Index for the third quarter at 8:30 a.m., Chicago PMI for October at 9:45 a.m., and the University of Michigan's final sentiment index for October at 10 a.m.

3. -- U.S. stocks on Thursday kept things mellow, drifting between slight losses and the flatline in a quieter session compared to Wednesday's blowout end to the day.  AB InBev, the world's largest brewer, said volume of its three top beers rose 11.5% in the quarter. The company's global brand revenue rose by 15.9%.
6. --  Starbucks (SBUX) - Get Report reported fiscal fourth-quarter earnings on Thursday of 43 cents a share, meeting analysts' forecasts, but the specialty coffee company issued a modest profit forecast for the fiscal first quarter of next year. Must Read: 5 Biotech Stocks Under $10 Triggering Breakout Trades

The S&P 500 fell 0.05% on Thursday, the Dow Jones Industrial Average fell 0.13%, and the Nasdaq declined 0.42%.

4. -- Valeant Pharmaceuticals (VRX) said Friday it was severing all ties with Philidor Rx Services, and that Philidor informed Valeant it would shut down operations as soon as possible.

"The newest allegations about activities at Philidor raise additional questions about the company's business practices," said J. Michael Pearson, Valeant's chairman and CEO, in a statement. "We have lost confidence in Philidor's ability to continue to operate in a manner that is acceptable to Valeant and the patients and doctors we serve."

Valeant uses pharmacies like Philidor to help deliver its drugs more quickly to patients through the mail. But analyst reports and news stories in the past week have questioned the Canadian drugmaker's financial relationship with the pharmacy. Short seller researcher firm Citron accused Valeant of using Philidor to create a network of "phantom pharmacies" to beef up its sales picture.

Earlier this week, Valeant said it was creating a special board committee to examine issues surrounding Philidor, including why the company was denied a permit last year to operate in California. The state's pharmacy board cited, among other reasons, false statements about Philidor's ownership and operations.

On Thursday, the nation's two largest pharmacy benefit providers -- CVS and Express Scripts -- said they were cutting ties with Philidor.

5. -- Anheuser-Busch InBev (BUD) - Get Report said third-quarter earnings before interest, taxes, depreciation and amortization rose 9.6% from a year earlier to $4.403 billion while revenue increased 7.9%.

The brewer clinched a tentative deal this month to take over its nearest rival SABMiller. If the deal is completed the combined company would control nearly a third of the global market.

Starbucks said it expects earnings during the next quarter of 44 cents to 45 cents a share, below Wall Street estimates of 47 cents.

Revenue in the fourth quarter rose 18% to $4.91 billion while same-store sales jumped 8%.

7. -- American International Group (AIG) - Get Report directors are discussing a spinoff or sale of the insurance giant's small mortgage-insurance business as AIG faces new shareholder pressure to break apart, people familiar with the situation told The Wall Street Journal.

The discussions have been under way for a while, and no final decision has been made about the unit, which sells coverage that protects mortgage investors and lenders against losses, the people told the newspaper. An AIG spokesman declined to comment.

AIG's mortgage-insurance operation is considerably smaller than AIG's other businesses, representing roughly 5% of pretax operating profit during the second quarter. But it posted the largest increase in pretax income during the first six months of 2015, the Journal noted.

8. -- LinkedIn (LNKD) , the professional networking service, posted a third-quarter loss wider than a year earlier but adjusted profit during the period topped analysts' forecasts.

The loss in the quarter was $40.5 million, or 31 cents a share. But stripping out expenses for employees' stock compensations and accounting costs for past acquisitions, earnings would have been 78 cents a share, surpassing forecasts of 47 cents.

Revenue in the quarter rose 37% to $780 million, topping forecasts.

9.--KeyCorp (KEY) - Get Report  is in advanced talks to buy First Niagara Financial Group (FNFG) , people familiar with the matter told the Journal.

The deal could value Buffalo, N.Y.-based First Niagara at a modest premium to its market capitalization of just under $4 billion, the people said. 

It would be one of the biggest bank tie-ups of the year and would solidify 2015 as the biggest year for bank deals since the financial crisis, according to the Journal.

10. -- Earnings are expected Friday from Exxon Mobil (XOM) - Get Report , Chevron (CVX) - Get Report , Colgate-Palmolive (CL) - Get Report , CVS Health (CVS) - Get Report and Newell-Rubbermaid (NWL) - Get Report .